Vitamin D Maintenance May Benefit Patients With Advanced Melanoma
Drug Topics
AUGUST 4, 2023
Nearly 25% of people “have vitamin D blood levels that are too low or inadequate for bone and overall health,” according to the NIH.
Sat.Jul 29, 2023 - Fri.Aug 04, 2023
469 
New Alzheimer’s treatments are the tip of the iceberg in a long-stymied area of medicine
PharmaVoice
AUGUST 3, 2023
A smaller player in the Alzheimer’s space, Prothena is approaching the next phase of treatments, including prevention and clinical trial evolution.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
mRNA-1273 Vaccine Associated With Lower Risk of Adverse Events, Likelihood of COVID-19 Diagnosis
Pharmacy Times
AUGUST 4, 2023
Compared to the BNT162b2 vaccine, the mRNA-1273 vaccine was associated with a lower risk of adverse events, which investigators speculate was due to interrelated safety and efficacy.
MTHFR, Hashimoto’s and Nutrients
The Thyroid Pharmacist
AUGUST 4, 2023
You may have heard of the term “MTHFR gene mutation” and may be wondering what it is. First, I’d like to say that I prefer the term “MTHFR gene variation” rather than “mutation.” The word mutation makes it sound like there’s something wrong with the person, while variation is more empowering – and in my opinion, also more accurate. While the word “mutation” implies an occurrence that is rare, unnatural, or flawed, the MTHFR gene variation is common.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
JAK Inhibitors Safe, Effective For Hair Growth in Patients With Alopecia Areata
Drug Topics
AUGUST 3, 2023
A study found that patients achieved 50% improvement with JAK inhibitors compared to placebo.
A pharma banking on the success of past blockbusters
PharmaVoice
JULY 31, 2023
180 Life Sciences is on a mission to see if the anti-TNF technology that produced a blockbuster could work for a range of other conditions.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Winn-Dixie celebrates Twinn Week with back-to-school savings
Drug Store News
AUGUST 4, 2023
Winn-Dixie is offering more than 1,000 BOGO deals in-store and online.
The Power of Analytics for Pharmacy Service Marketing
Drug Topics
AUGUST 1, 2023
How many different ways can analytics assist your pharmacy? More than you may think. Mehrdad Hariri, RPh, CPh, MBA presented a session at July's Total Pharmacy Solution Summit on all the ways you can leverage those data for success.
PBMs could soon feel the regulatory sting
PharmaVoice
AUGUST 4, 2023
From Congress to the FTC to state legislatures, regulators are cracking the whip against PBMs.
Patients With Transthyretin Cardiac Amyloidosis, Heart Failure With Preserved Ejection Fraction Have Similar All-Cause Death Rates
Pharmacy Times
AUGUST 4, 2023
Notably, patients with transthyretin cardiac amyloidosis had higher rates of heart failure hospitalizations, including patients treated with tafamidis.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Industry Voices—Let's treat loneliness like other public health crises
Fierce Healthcare
AUGUST 4, 2023
A silent and grossly underserved epidemic of loneliness is affecting 60% of all America | Numerous experts have called attention to our loneliness epidemic, describing its negative health impact as similar to “smoking 15 cigarettes a day.
Chewable Tablet Receives FDA Approval for Internal and External Parasites in Dogs
Drug Topics
AUGUST 1, 2023
Afoxolaner, moxidectin, and pyrantel chewable tablets protect dogs from fleas, ticks, heartworm disease, roundworms, and hookworms.
Is the COVID-19 market crashing?
PharmaVoice
AUGUST 3, 2023
Pfizer’s recent earnings report could foretell major trouble in the market for pandemic products.
The Role of Specialty Pharmacists in Overcoming Barriers Associated With PCSK9 Inhibitors
Pharmacy Times
AUGUST 4, 2023
Specialty pharmacists play an important role in dispensing PCSK9 inhibitors and serve as a valuable source of assistance and education for patients.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
US FDA approves Merck’s Ebola vaccine for under-18s
Pharmaceutical Technology
AUGUST 4, 2023
The US FDA has granted approval for an expanded indication of Merck’s Ebola vaccine, Ervebo, for usage in the paediatric population.
Comparing Safety, Efficacy of COVID-19 mRNA Vaccines in Older Adults
Drug Topics
AUGUST 2, 2023
Moderna’s mRNA-1273 vaccine was associated with a lower risk of diagnosed COVID-19 when compared to Pfizer’s BNT162b2.
How CymaBay overcame a NASH failure for another shot at liver disease success
PharmaVoice
AUGUST 2, 2023
The biotech’s 2019 trial halt was a major disappointment in NASH, but a turnaround has shown late-stage potential in another liver disease with unmet needs.
CDC Advisory Committee on Immunization Practices Recommends Nirsevimab-alip to Prevent RSV in Infants
Pharmacy Times
AUGUST 4, 2023
CDC Advisory Committee on Immunization Practices voted 10 to 0 to recommend the routine use of nirsevimab-alip (Beyfortus; Sanofi and AstraZeneca) for the prevention of respiratory syncytial virus lower respiratory tract disease in newborns and infants.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Don’t take these medicines with Benadryl
The Checkup by Singlecare
AUGUST 4, 2023
When you experience symptoms of allergies, hay fever, or the common cold, all you want is a solution—fast. Benadryl quickly relieves symptoms of red, itchy, watery eyes, sneezing, runny nose, cough, and an itchy throat. For some people, it can help manage symptoms of insomnia, Parkinson’s disease, or motion sickness. But before seeking relief from Benadryl, you should know it does have certain drug interactions.
GSK’s RSV Vaccine Now Available in Some US Pharmacies: What You Need to Know
Drug Topics
AUGUST 1, 2023
A Q&A with Marc Ost, co-owner of Eric’s RX Shoppe, which was one of the first community pharmacies to receive the new vaccine.
As Barbie breaks the box office, women’s health investment explodes
PharmaVoice
AUGUST 1, 2023
Much like the year she first graced store shelves, Barbie has taken over the world. But now, the women's health landscape looks a whole lot different.
Oncology Pharmacists Influencing the MM Treatment Landscape
Pharmacy Times
AUGUST 4, 2023
Drs Haumschild, Anderson, and Hinojosa provide their closing thoughts regarding treatment considerations for patients with RRMM.
New HIV drug formulation could transform paediatric administration
European Pharmaceutical Review
AUGUST 4, 2023
A new study published in The Lancet HIV has demonstrated the safety and efficacy of a new dispersible drug formulation of an immediate-release tablet as a human immunodeficiency virus (HIV) treatment for children. The single fixed dose combination (FDC) contains dolutegravir , abacavir and lamivudine. “This is the first FDC containing dolutegravir that can be used for children from 13 to 88 pounds,” explained Kristina Brooks, PharmD, an Assistant Professor in the University of Colorado Skaggs Sc
Q&A With the Finalists for Health Mart Pharmacy of the Year
Drug Topics
AUGUST 1, 2023
Hear the pharmacists from Eden Drug, Hazel Green, and Professional Pharmacy on their reactions to being a finalist for this award and more.
Putting purpose over profits, this pharma takes on the important issues
PharmaVoice
AUGUST 1, 2023
Afaxys is a self-described "socially conscious" contraceptive healthcare company serving an unusual demographic for pharma: the public health sector.
Military-Related Traumatic Brain Injury a Risk Factor for New-Onset Mental Health Conditions
Pharmacy Times
AUGUST 3, 2023
The risk of death by suicide in soldiers was both directly and indirectly related to traumatic brain injury through confounding mental health diagnoses.
Data breach exposes information on 1.7M Oregon Health Plan members
Fierce Healthcare
AUGUST 4, 2023
State officials are urging members of the Oregon Health Plan to monitor their credit accounts as personal data on nearly 1.7 members was exposed as part of a massive data breach into a contractor.< | State officials are urging members of the Oregon Health Plan to monitor their credit accounts as personal data on nearly 1.7 members was exposed as part of a massive data breach into a contractor.
FDA Gives 510(k) Clearance to COVID-19, Influenza A/B, RSV Combination Test
Drug Topics
AUGUST 4, 2023
A 510(k) clearance, or a Premarket Notification, requires device manufacturers to notify the FDA at least 90 days ahead of registration with their intent to market a medical device.
Pandemic slowed cancer diagnoses, but late-stage cancers came back with a vengeance
STAT
AUGUST 4, 2023
Early-stage cancer diagnoses decreased by nearly 20% in the first year of the Covid-19 pandemic. A new study published in Lancet Oncology emphasizes how, because of disruptions in care, patients were more likely to get diagnosed with deadly metastatic disease — across nearly all cancer types. This study is the most comprehensive analysis of cancer diagnoses during the pandemic, using a nationwide registry that captures over 70% of all cancers in the United States.
Effect of Pharmacist Recommendation on Antibiotic Duration Prescribing at Hospital Discharge
Pharmacy Times
AUGUST 3, 2023
Antibiotic prescribing at hospital discharge is a component of pharmacist-led antimicrobial stewardship programs that is often overlooked.
Giant donates $100K to Helping Harvest Fresh Food Bank
Drug Store News
AUGUST 4, 2023
The donation will help provide more than 9,000 bags of food to be distributed to preschool and elementary children, designed to replace food that those kids would normally have received at school.
COPD Exacerbations Common in Patients Not Treated With Controller Medications
Drug Topics
AUGUST 4, 2023
A study found that although the number of patients receiving a controller medication increased after their first exacerbation, the percentage given controller medications remained below 50% among the overall population.
STAT+: Medicare slashes safety net hospital payments on estimate that more people have insurance
STAT
AUGUST 4, 2023
The federal government will pay hospitals that treat poor and uninsured patients almost $1 billion less next year, a cut that’s more than eight times larger than the one proposed in April. The Centers for Medicare and Medicaid Services originally said it would cut payments meant to help safety net hospitals by $115 million in 2024. In the final rule released this week, however, that cut grew to $957 million.
Let's personalize your content